Market News
Wednesday, June 22, 2016
BRIEF-Karyopharm says initiates phase 1 clinical trial with KPT-9274
* Says first-In-Human, multi-center, open-label,
dose-escalation trial is expected to enroll up to 175 patients
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment